China, Nov. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A 24-week real-world study of Upadacitinib in the treatment of patients with moderate to severe hidradenitis suppurative'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136808

Registration Time: 2026/11/16

Type: Observational study

Primary Sponsor: Peking Union Medical College Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=352729

Published by HT Digital Content Services with permission from Health Daily Digest....